Search
for
Sort by
Research 871–900 of 1000+
- UP-02.010 Urinary PSA: Marker of Benign Prostatic Hyperplasia?
- UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood
- News in brief
- Abstract 5561: 20(S)-Protopanaxadiol-aglycone downregulates full-length and ligand-independent splice variants of androgen receptor
- Effects of Yiqi Huayu Chinese Medicine on the Expression of MMP-2/TIMP-2 in BPH Rats
- S2 PSA: RELIABLE OR NOT RELIABLE?
- S4 URETHRAL PSA LEVELS AFTER RADICAL PROSTATECTOMY
- Crystal Structure and Synthesis of 17α-Acetoxy-pregn-4,6-diene-3,20-dione
- Incidence of serious infectious events with methotrexate treatment: Metaanalysis of randomized controlled trials
- Non-competitive androgen receptor inhibition in vitro and in vivo
- S90 Urethral PSA production after radical prostatectomy
- DOES PSADT AFTER RADICAL PROSTATECTOMY PREDICT OVERALL SURVIVAL?—A REPORT FROM THE SEARCH DATABASE GROUP
- NEURONAL MIMICRY AS A RESISTANCE PHENOTYPE IN CANCER CELLS
- CAN PATIENTS WITH LUTS AND BPH DISCERN CHANGES IN PEAK URINARY FLOW RATE AND DO SUCH CHANGES CONTRIBUTE TO OVERALL SATISFACTION WITH TREATMENT?
- The influence of secoisolariciresinol diglusoside on non-emasculated rat in BPH
- Association between PSA and leptin, adiponectin, HbA1c, or C-peptide among African-American and Caucasian men
- 토마토 추출액 복합체가 전립선 암 세포와 전립선 비대증에 미치는 영향
- Urological Oncology: Testis Cancer and Advances in Oncological Therapy
- Effect of Low-Dose Finasteride on Serum PSA Concentrations
- UP-03.20
- UP-02.28
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?
- Editorial comment 1
- Latent hazard in PC and BPH patients referred to antiandrogens:PC aggressiveness and NE differentiation
- PCPT Results Could Affect Trial on Testosterone Replacement
- Australian Hair and Wool Research Society Cutaneous Biology and Endocrinology Workshop
- Impact of baseline PSA level on quality of life measures of general health and sexual satisfaction/drive in men with BPH treated with finasteride or placebo
- Androstenedione
- 17α-Acetoxy-6-bromo-16β-methylpregna-4,6-diene-3,20-dione